CIBC Bancorp USA’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIX
CIBC Bancorp USA's ANIX Position: Q3 2026 in Review
CIBC Bancorp USA increased its Anixa Biosciences (ANIX) stake by 100% in Q3 2026, buying an estimated $85.6K and bringing the position to 53,200 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #2041.
CIBC Bancorp USA first reported a position in ANIX in Q1 2026 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.
- CIBC Bancorp USA held 53,200 shares of Anixa Biosciences worth $156K as of Q3 2026.
- CIBC Bancorp USA bought 26,600 Anixa Biosciences shares in Q3 2026, an estimated $85.6K.
- Anixa Biosciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #2041 holding.
- CIBC Bancorp USA first reported a position in Anixa Biosciences in Q1 2026 and has held it in 3 quarters since.
- 75 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.